Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $185,628 - $202,428
600 Added 20.0%
3,600 $1.16 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $446,675 - $542,827
-1,700 Reduced 36.17%
3,000 $937,000
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $107,548 - $129,824
400 Added 9.3%
4,700 $1.34 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $1.18 Million - $1.33 Million
-4,600 Reduced 51.69%
4,300 $1.24 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $940,195 - $1.17 Million
-4,300 Reduced 32.58%
8,900 $2.39 Million
Q2 2023

Aug 15, 2023

SELL
$214.27 - $253.37 $1.11 Million - $1.32 Million
-5,200 Reduced 28.26%
13,200 $2.93 Million
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $4.02 Million - $4.9 Million
-17,800 Reduced 49.17%
18,400 $4.45 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $6.12 Million - $7.77 Million
-26,700 Reduced 42.45%
36,200 $9.51 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $5.84 Million - $6.58 Million
26,000 Added 70.46%
62,900 $14.2 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $8.09 Million - $8.95 Million
36,890 Added 368900.0%
36,900 $8.92 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $1,822 - $2,417
10 New
10 $17,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.